Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Rösler TW[au]:

PERK activation mitigates tau pathology <i>in vitro</i> and <i>in vivo</i>. Bruch J et al. EMBO Mol Med. (2017)

Tau silencing by siRNA in the P301S mouse model of tauopathy. Xu H et al. Curr Gene Ther. (2014)

Four-repeat tauopathies. Rösler TW et al. Prog Neurobiol. (2019)

Search results

Items: 23

1.

Tau links developmental to neurodegenerative diseases.

Rösler TW, Höglinger GU.

Neurosci Biobehav Rev. 2019 Sep;104:26-27. doi: 10.1016/j.neubiorev.2019.06.015. Epub 2019 Jun 26. No abstract available.

PMID:
31254540
2.

Four-repeat tauopathies.

Rösler TW, Tayaranian Marvian A, Brendel M, Nykänen NP, Höllerhage M, Schwarz SC, Hopfner F, Koeglsperger T, Respondek G, Schweyer K, Levin J, Villemagne VL, Barthel H, Sabri O, Müller U, Meissner WG, Kovacs GG, Höglinger GU.

Prog Neurobiol. 2019 Sep;180:101644. doi: 10.1016/j.pneurobio.2019.101644. Epub 2019 Jun 22. Review.

PMID:
31238088
3.

Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease.

Hopfner F, Wod M, Höglinger GU, Blaabjerg M, Rösler TW, Kuhlenbäumer G, Christensen K, Deuschl G, Pottegård A.

Neurology. 2019 Jul 9;93(2):e135-e142. doi: 10.1212/WNL.0000000000007694. Epub 2019 May 24.

PMID:
31127070
4.

Multiple molecular pathways stimulating macroautophagy protect from alpha-synuclein-induced toxicity in human neurons.

Höllerhage M, Fussi N, Rösler TW, Wurst W, Behrends C, Höglinger GU.

Neuropharmacology. 2019 May 1;149:13-26. doi: 10.1016/j.neuropharm.2019.01.023. Epub 2019 Feb 4.

PMID:
30731136
5.

Halogen-substituted anthranilic acid derivatives provide a novel chemical platform for androgen receptor antagonists.

Roell D, Rösler TW, Hessenkemper W, Kraft F, Hauschild M, Bartsch S, Abraham TE, Houtsmuller AB, Matusch R, van Royen ME, Baniahmad A.

J Steroid Biochem Mol Biol. 2019 Apr;188:59-70. doi: 10.1016/j.jsbmb.2018.12.005. Epub 2019 Jan 4.

PMID:
30615932
6.

K-variant BCHE and pesticide exposure: Gene-environment interactions in a case-control study of Parkinson's disease in Egypt.

Rösler TW, Salama M, Shalash AS, Khedr EM, El-Tantawy A, Fawi G, El-Motayam A, El-Seidy E, El-Sherif M, El-Gamal M, Moharram M, El-Kattan M, Abdel-Naby M, Ashour S, Müller U, Dempfle A, Kuhlenbäumer G, Höglinger GU.

Sci Rep. 2018 Nov 8;8(1):16525. doi: 10.1038/s41598-018-35003-4.

7.

[Tauopathies : From molecule to therapy].

Kovacs GG, Respondek G, van Eimeren T, Höller E, Levin J, Müller U, Schwarz S, Rösler TW, Schweyer K, Höglinger GU.

Nervenarzt. 2018 Oct;89(10):1083-1094. doi: 10.1007/s00115-018-0584-3. Review. German.

PMID:
30120488
8.

Exosomal secretion of α-synuclein as protective mechanism after upstream blockage of macroautophagy.

Fussi N, Höllerhage M, Chakroun T, Nykänen NP, Rösler TW, Koeglsperger T, Wurst W, Behrends C, Höglinger GU.

Cell Death Dis. 2018 Jul 9;9(7):757. doi: 10.1038/s41419-018-0816-2.

9.

c.207C>G mutation in sepiapterin reductase causes autosomal dominant dopa-responsive dystonia.

Shalash AS, Rösler TW, Müller SH, Salama M, Deuschl G, Müller U, Opladen T, Petersen BS, Franke A, Hopfner F, Kuhlenbäumer G, Höglinger GU.

Neurol Genet. 2017 Nov 1;3(6):e197. doi: 10.1212/NXG.0000000000000197. eCollection 2017 Dec.

10.

Protective efficacy of phosphodiesterase-1 inhibition against alpha-synuclein toxicity revealed by compound screening in LUHMES cells.

Höllerhage M, Moebius C, Melms J, Chiu WH, Goebel JN, Chakroun T, Koeglsperger T, Oertel WH, Rösler TW, Bickle M, Höglinger GU.

Sci Rep. 2017 Sep 13;7(1):11469. doi: 10.1038/s41598-017-11664-5.

11.

PERK activation mitigates tau pathology in vitro and in vivo.

Bruch J, Xu H, Rösler TW, De Andrade A, Kuhn PH, Lichtenthaler SF, Arzberger T, Winklhofer KF, Müller U, Höglinger GU.

EMBO Mol Med. 2017 Mar;9(3):371-384. doi: 10.15252/emmm.201606664.

12.

Chronic consumption of Annona muricata juice triggers and aggravates cerebral tau phosphorylation in wild-type and MAPT transgenic mice.

Rottscholl R, Haegele M, Jainsch B, Xu H, Respondek G, Höllerhage M, Rösler TW, Bony E, Le Ven J, Guérineau V, Schmitz-Afonso I, Champy P, Oertel WH, Yamada ES, Höglinger GU.

J Neurochem. 2016 Nov;139(4):624-639. doi: 10.1111/jnc.13835. Epub 2016 Sep 16.

13.

Neurotoxicity of Dietary Supplements from Annonaceae Species.

Höllerhage M, Rösler TW, Berjas M, Luo R, Tran K, Richards KM, Sabaa-Srur AU, Maia JG, Moraes MR, Godoy HT, Höglinger GU, Smith RE.

Int J Toxicol. 2015 Nov-Dec;34(6):543-50. doi: 10.1177/1091581815602252. Epub 2015 Sep 24.

PMID:
26405269
14.

Tau silencing by siRNA in the P301S mouse model of tauopathy.

Xu H, Rösler TW, Carlsson T, de Andrade A, Fiala O, Hollerhage M, Oertel WH, Goedert M, Aigner A, Höglinger GU.

Curr Gene Ther. 2014;14(5):343-51.

PMID:
25687501
15.

Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.

Depboylu C, Rösler TW, de Andrade A, Oertel WH, Höglinger GU.

J Neurochem. 2015 May;133(4):590-7. doi: 10.1111/jnc.13026. Epub 2015 Jan 26.

16.

Piericidin A aggravates Tau pathology in P301S transgenic mice.

Höllerhage M, Deck R, De Andrade A, Respondek G, Xu H, Rösler TW, Salama M, Carlsson T, Yamada ES, Gad El Hak SA, Goedert M, Oertel WH, Höglinger GU.

PLoS One. 2014 Dec 1;9(12):e113557. doi: 10.1371/journal.pone.0113557. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0122907.

17.

Diesterified derivatives of 5-iodo-2'-deoxyuridine as cerebral tumor tracers.

Rösler TW, Matusch A, Librizzi D, Arias-Carrión O, Freundlieb N, Hoeffken H, Oertel WH, Depboylu C, Höglinger GU.

PLoS One. 2014 Jul 16;9(7):e102397. doi: 10.1371/journal.pone.0102397. eCollection 2014.

18.

Memory deficits correlate with tau and spine pathology in P301S MAPT transgenic mice.

Xu H, Rösler TW, Carlsson T, de Andrade A, Bruch J, Höllerhage M, Oertel WH, Höglinger GU.

Neuropathol Appl Neurobiol. 2014 Dec;40(7):833-43. doi: 10.1111/nan.12160.

PMID:
24865638
19.

Biodistribution and brain permeability of the extracellular domain of neuregulin-1-β1.

Rösler TW, Depboylu C, Arias-Carrión O, Wozny W, Carlsson T, Höllerhage M, Oertel WH, Schrattenholz A, Höglinger GU.

Neuropharmacology. 2011 Dec;61(8):1413-8. doi: 10.1016/j.neuropharm.2011.08.033. Epub 2011 Aug 31.

PMID:
21903113
20.

Systemic administration of neuregulin-1β1 protects dopaminergic neurons in a mouse model of Parkinson's disease.

Carlsson T, Schindler FR, Höllerhage M, Depboylu C, Arias-Carrión O, Schnurrbusch S, Rösler TW, Wozny W, Schwall GP, Groebe K, Oertel WH, Brundin P, Schrattenholz A, Höglinger GU.

J Neurochem. 2011 Jun;117(6):1066-74. doi: 10.1111/j.1471-4159.2011.07284.x. Epub 2011 May 13.

21.

Antiandrogenic activity of anthranilic acid ester derivatives as novel lead structures to inhibit prostate cancer cell proliferation.

Roell D, Rösler TW, Degen S, Matusch R, Baniahmad A.

Chem Biol Drug Des. 2011 Jun;77(6):450-9. doi: 10.1111/j.1747-0285.2011.01116.x. Epub 2011 Apr 27.

PMID:
21439024
22.

Zonisamide: aspects in neuroprotection.

Rösler TW, Arias-Carrión O, Höglinger GU.

Exp Neurol. 2010 Aug;224(2):336-9. doi: 10.1016/j.expneurol.2010.04.017. Epub 2010 May 4.

PMID:
20450911
23.

Analysis of the hydrodistillate from the fruits of Serenoa repens.

Rösler TW, Matusch R, Weber B, Schwarze B.

Planta Med. 2009 Feb;75(2):184-6. doi: 10.1055/s-0028-1088392. Epub 2009 Jan 12.

PMID:
19140098

Supplemental Content

Loading ...
Support Center